Seung-Yeon Jung

发表

Prognostic significance of FDG-PET/CT in determining upfront autologous stem cell transplantation for the treatment of peripheral T cell lymphomas

Sae-Ryung Kang, H. Yhim, Je-Jung Lee, 2019, Annals of Hematology.

Pralatrexate in Combination with Bortezomib for Relapsed or Refractory Peripheral T Cell Lymphoma in Elderly Patients: a Pilot Trial

Je-Jung Lee, Hyeoung-Joon Kim, Deok-Hwan Yang, 2016 .

Optimal chemo-mobilization for the collection of peripheral blood stem cells in patients with multiple myeloma

Je-Jung Lee, Hyeoung-Joon Kim, Deok-Hwan Yang, 2019, BMC Cancer.

Salvage chemotherapy with R-BAD (rituximab, bendamustine, cytarabine, and dexamethasone) for the treatment of relapsed primary CNS lymphoma

Deok-Hwan Yang, Ga-Young Song, Seo-Yeon Ahn, 2016, Blood research.

Optimal chemo-mobilization for the collection of peripheral blood stem cells in patients with multiple myeloma

Je-Jung Lee, Hyeoung-Joon Kim, Deok-Hwan Yang, 2019, BMC Cancer.

Allogeneic transplant can abrogate the risk of relapse in the patients of first remission acute myeloid leukemia with detectable measurable residual disease by next-generation sequencing

Zhaolei Zhang, Je-Jung Lee, Hyeoung-Joon Kim, 2020, Bone Marrow Transplantation.

Remission clone in acute myeloid leukemia shows growth advantage after chemotherapy but is distinct from leukemic clone.

Zhaolei Zhang, S. Ogawa, Kenichi Yoshida, 2019, Experimental hematology.

18F-FDG PET/CT is useful for determining survival outcomes of patients with multiple myeloma classified as stage II and III with the Revised International Staging System

J. Min, Je-Jung Lee, H. Bom, 2018, European Journal of Nuclear Medicine and Molecular Imaging.

Pralatrexate in Combination with Bortezomib for Relapsed or Refractory Peripheral T Cell Lymphoma in 5 Elderly Patients

Je-Jung Lee, Hyeoung-Joon Kim, Deok-Hwan Yang, 2016, Journal of Korean medical science.